FundedIQ
Biotechnology

Protai: Funding, Investors & Team (Sep 2026)

Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.

www.protai.bio LinkedIn Tel Aviv, Israel 11-50 employees
Biotechnology Life Science
Total raised
$20.0M
Rounds
2
Latest
Seed
Mar 2023

Protai has raised $20.0M across 2 funding rounds on record, the most recent a Seed of $12.0M announced in Mar 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Protai Company Profile and Key Stats

Total funding raised
$20.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$12.0M in Mar 2023
Employees
11-50
reported band
Headquarters
Tel Aviv, Israel

Latest funding round on record: Mar 2023.

Protai Funding Rounds

Date
Round
Amount
Seed
$12.0M
Seed
$8.0M

Protai raised $8.0M in a Seed announced in Jan 2022.

1.2 years later, a Seed of $12.0M was announced in Mar 2023.

Protai Founders and Leadership Team

Name
Role
Contact
Eran Seger
CEO
Locked

Contact details for the Protai team: 1 of 1 has an email address on file.

Start 14-day free trial →

Protai Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
1,015
$14M
16,575
$3.1M

Protai's latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Protai in Biotechnology and Tel Aviv

Companies Similar to Protai

CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…

Undisclosed round $2.6M

Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…

Seed $150k

Brevel has created an innovative method of cultivating microalgae that is both sustainable and…

Undisclosed round $1.0M

RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…

Undisclosed round $6.0M

Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…

Undisclosed round $6.5M

IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…

Undisclosed round $5.5M

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…

Undisclosed round $13.0M

Phytolon is transforming the process of creating food colors by using an innovative and environmentally…

Series B $23.6M

BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…

Undisclosed round $47.8M

SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…

Series A $6.0M

ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…

Undisclosed round $14.0M

MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…

Seed $3.6M

Protai Funding FAQs

What does Protai do?

Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.

How much funding has Protai raised?

Protai has raised $20.0M across 2 rounds on record. The most recent is a Seed of $12.0M announced in Mar 2023.

When did Protai last raise funding?

Protai's most recent funding round on record is a Seed of $12.0M, announced in Mar 2023.

Who is the CEO of Protai?

Eran Seger is listed as CEO at Protai.

Where is Protai headquartered?

Protai is based in Tel Aviv, Israel.

How many employees does Protai have?

Protai is in the 11-50 employee band.

How does Protai's funding compare to other Biotechnology startups?

Protai's latest round of $12.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Protai Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Protai is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.